Atherosclerosis patents: clues to the next drug generation.
Suckling
K E
KE
Department of Vascular Biology, SmithKline Beecham Pharmaceuticals Research and Development, Welwyn, Hertfortshire, U.K.
D001161:Arteriosclerosis / Q000188:drug therapy*; D001709:Biotechnology; D016527:Drug Costs; D015195:Drug Design; D016568:Drugs, Generic / Q000191:economics*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010330:Patents as Topic; D013678:Technology, Pharmaceutical
D016568:Drugs, Generic; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors